Navigation Links
ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer

Lung cancer, the header among all forms of cancer, is avenged now by the new proven effective ZD1839.

It has been shown that ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, has confirmed, durable responses and safety in patients with advanced non-small cell lung cancer (NSCLC) as monotherapy and in combination with standard chemotherapy agents after segmental scrutinization in two different studies.

Vincent Miller, MD, of Memorial Sloan-Kettering Cancer Center in New York and the principal investigator of the first study said, "It is hoped that our study will be a prelude to better outcomes for NSCLC patients in the near future." No novel toxicities were seen with ZD1839 treatment in combination with standard chemotherapy.

In a second study, which addressed intermittent dosing of ZD1839 in Japanese patients with advanced lung cancer, more than 20% of patients showed partial responses to ZD1839 between 1 and 11 months.

With such promising results, researchers are now working on whether this drug can be used for other forms of cancer as well.

Page: 1

Related medicine news :

1. Study Proves That MMR Vaccine Is Not Connected To Autistic Babies
2. Pilot Study Proves Home Abortions ‘Safe’
3. Many Nonprescription Cough Medicines Proves Ineffective
4. Less Invasive By Pass Surgery Proves Economical In The Long Run
5. Epidural Mistakes Proves To Be Fatal Blunders
6. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
7. Drug Trial Proves Nightmare for British Indian Student
8. Naturopathic Care Proves Beneficial for TMD Pain
9. Medtronic Device Proves Effective in Parkinson’s Diseas
10. Large Community Spirometry Screening Proves Successful
11. Pregabalin Proves Durable Pain Relief Option for Fibromyalgia
Post Your Comments:

(Date:11/26/2015)... ... November 26, 2015 , ... ... mental health and wellness consultation, has collaborated with Women’s Web – an ... reader’s queries on topics on mental and emotional well-being relationship, life balance, ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology: